Financial Analyst Keynote: How CMOs can Support the Overarching Process of a Fundraising

Dr Elena Lovo is an Executive Director in the Healthcare Investment Banking group at JP Morgan where she works with Biotech clients in Europe. During her 6 years in banking, she has been supporting several companies in their strategic and capital formation journey. Before moving into banking, Elena worked in strategy consulting and in transaction advisory, mainly supporting pharma and biotech clients on product licensing and M&A transactions.Elena received a PhD in Immunology from Imperial College London, spent some time working in Prof R. Gallo’s lab at the Institute of Human Virology in Baltimore, MD, and has Masters of Science in Medical Biotechnologies from San Raffaele University in Milan.

Nerissa C Kreher, MD, MBA is an accomplished physician executive and pediatric endocrinologist with strong biotech experience in Clinical Development and Medical Affairs. Her expertise is in the development of therapies for patients with rare diseases across multiple therapeutic areas. She has participated in corporate growth of multiple biotech companies via VC fundraising events as well as IPOs. She previously served as CMO at Tiburio Therapeutics and AVROBIO. Currently, Nerissa is the Chief Medical Officer at Entrada Therapeutics and serves on the Board of Directors of Rezolute Bio.